Effect of tuberculinum in comparison with individualised homoeopathic medicine in decreasing episodes of recurrent respiratory tract infections in children

Efficacy of Tuberculinum in comparison with Individualised Homoeopathic medicine in reducing episodes of recurrent respiratory tract infections in children: A comparative, single blind, clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073187

Enrollment

120

Registered

2024-09-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J06- Acute upper respiratory infectionsof multiple and unspecified sites

Interventions

Intervention1: Tuberculinum: Start with one dose of Tuberculinum 1M orally If required medicine will be repeated or placebo powder will be given total duration 1 year Control Intervention1: INDIV

Eligibility

Inclusion criteria

Inclusion criteria: Children with recurrent respiratory tract infections more or equal 8 episodes per year if aged less than 3 years more or equal 6 episodes per year if aged more or equal 3 years

Exclusion criteria

Exclusion criteria: Lower Respiratory Tract Infections will be excluded K/C/O history of Tuberculosis Children with congenital anomaly affecting upper respiratory tract. Children with Immunocomprised diseases and other co-morbidities.

Design outcomes

Primary

Measure	Time frame
reduction in the number of episodes of respiratory tract infection.Timepoint: 1 year	—

Secondary

Measure	Time frame
effect of tuberculinum in reducing recurrence of respiratory tract infectionsTimepoint: 1 year	—

Countries

India

Contacts

Public ContactDr Snehal Bhagavan Patil

YMT Homoeopathic medical college and PG Institute

drvasika@gmail.com09821351671

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026